Sharon Shacham
2012
In 2012, Sharon Shacham earned a total compensation of $456.3K as President and Chief Scientific Officer at Karyopharm Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $138,800 |
|---|---|
| Option Awards | $5,460 |
| Salary | $300,000 |
| Other | $12,060 |
| Total | $456,320 |
Shacham received $300K in salary, accounting for 66% of the total pay in 2012.
Shacham also received $138.8K in non-equity incentive plan, $5.5K in option awards and $12.1K in other compensation.
Rankings
In 2012, Sharon Shacham's compensation ranked 9,028th out of 11,487 executives tracked by ExecPay. In other words, Shacham earned more than 21.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,028 out of 11,487 | 21st |
Division Manufacturing | 3,306 out of 4,253 | 22nd |
Major group Chemicals And Allied Products | 889 out of 1,198 | 26th |
Industry group Drugs | 656 out of 920 | 29th |
Industry Pharmaceutical Preparations | 508 out of 700 | 27th |
Source: SEC filing on April 28, 2014.
Shacham's colleagues
We found one more compensation record of an executive who worked with Sharon Shacham at Karyopharm Therapeutics in 2012.
2012
Michael Kauffman
Karyopharm Therapeutics
Chief Executive Officer
News
Karyopharm Therapeutics CEO Richard Paulson receives $8.4M in 2021
April 8, 2022
Karyopharm Therapeutics CEO Michael Kauffman's 2020 pay jumps 22% to $3.9M
April 7, 2021
Karyopharm Therapeutics CEO Michael Kauffman's 2019 pay jumps 42% to $3.2M
April 9, 2020
Karyopharm Therapeutics Executive Vice President, Chief Commercial Officer Anand Varadan receives $2.3M in 2018
April 19, 2019